Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 7877

Shane DiGiovanna Act

Refreshed 45 min ago

Introduced 2026-03-09Topic: health care · social services

Summary

AI-generated summary, report an error

This bill would require the federal Department of Health and Human Services to run a 2-year nationwide test program, starting within 1 year of the law passing. During the program, state Medicaid plans would have to cover certain items used to treat the skin condition epidermolysis bullosa for certain eligible people. Covered items would include over-the-counter pain relievers, antihistamines, antiseptics, zinc oxide, antibiotic ointments, and wound care supplies such as dressings, gauze, and bandage retainers. Within 1 year after the program ends, the department would report to Congress on its effects on Medicaid spending and health outcomes, along with any recommendations on preventing related hospital stays.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-03-17Sponsor introductory remarks on measure. (CR H2535)
2026-03-09HouseReferred to the House Committee on Energy and Commerce.refer
2026-03-09Introduced in Houseintroduce
2026-03-09Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.